Table 2

Infectious complications after rituximab therapy for ITP

Sex, age (y)Duration of ITP (mo)Splenectomy before rituximab treatmentSite of infectionInfectious agentsDelay after first rituximab infusion, monthsAdmission to hospital/parenteral antibioticsCurrent treatment with steroidsLast gammaglobulin level (g/L)Outcome
F, 38 16 No Pulmonary ND −/+ No NA Recovery 
M, 67 No Cutaneous ND −/+ No 12.4 Recovery 
F, 37 No Pulmonary Streptococcus pneumoniae 18 +/+ No 10.2 Recovery 
M, 71 119 No Flu-like syndrome ND −/− No NA Recovery 
M, 73 No Bone, septic shock Aureus Staphylococcus 13 +/+ Yes NA Death 
M, 70 19 Yes Pulmonary Enterococcus faecium 12 +/+ Yes 5.4 Death 
F, 74 No Urinary tract Escherichia coli +/+ Yes 6.2 Recovery 
   Sinus Aspergillus fumigatus −/+ Yes 6.2 Recovery 
   Pulmonary ND 2.5 −/+ Yes 6.4 Recovery 
   Urinary tract Streptococcus, group D −/+ Yes NA Recovery 
   Septic shock Enterobacter cloacae 14 +/+ Yes NA Death 
Sex, age (y)Duration of ITP (mo)Splenectomy before rituximab treatmentSite of infectionInfectious agentsDelay after first rituximab infusion, monthsAdmission to hospital/parenteral antibioticsCurrent treatment with steroidsLast gammaglobulin level (g/L)Outcome
F, 38 16 No Pulmonary ND −/+ No NA Recovery 
M, 67 No Cutaneous ND −/+ No 12.4 Recovery 
F, 37 No Pulmonary Streptococcus pneumoniae 18 +/+ No 10.2 Recovery 
M, 71 119 No Flu-like syndrome ND −/− No NA Recovery 
M, 73 No Bone, septic shock Aureus Staphylococcus 13 +/+ Yes NA Death 
M, 70 19 Yes Pulmonary Enterococcus faecium 12 +/+ Yes 5.4 Death 
F, 74 No Urinary tract Escherichia coli +/+ Yes 6.2 Recovery 
   Sinus Aspergillus fumigatus −/+ Yes 6.2 Recovery 
   Pulmonary ND 2.5 −/+ Yes 6.4 Recovery 
   Urinary tract Streptococcus, group D −/+ Yes NA Recovery 
   Septic shock Enterobacter cloacae 14 +/+ Yes NA Death 

NA, not available; ND, not determined.

Close Modal

or Create an Account

Close Modal
Close Modal